切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Calpains - Valosin-containing protein (VCP) - Inward Rectifier Potassium (Kir) Channels

12件产品中的 1-10

页面
每页
清除全部
  1. Nateglinide
    B2198 Nateglinide
    中文名: 那格列奈
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素促分泌剂
      ≥16.4 mg/mL
      insoluble in H2O
  2. Gliclazide
    B2195 Gliclazide
    中文名: 格列齐特
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥15.6 mg/mL
      insoluble in H2O
  3. Mitiglinide Calcium
    B2193 Mitiglinide Calcium
    中文名: 米格列奈钙
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥33.45 mg/mL
      insoluble in H2O
  4. Glibenclamide
    B1296 Glibenclamide
    中文名: 格列本脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素生产调节剂
      ≥49.4 mg/mL
      insoluble in H2O
  5. NMS-873
    B2168 NMS-873
     3 Citation
    Target: Valosin-containing protein (VCP)
    Summary: VCP/p97抑制剂
      ≥17.1 mg/mL
      insoluble in H2O
  6. Terfenadine
    A8534 Terfenadine
    中文名: 特非那定
    Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) Channels
    Summary: 组胺H1受体拮抗剂
      ≥18 mg/mL
      insoluble in H2O
  7. PD 150606
    A4413 PD 150606
    Target: Calpains
    Summary: 非肽类钙蛋白酶抑制剂
      Soluble in DMSO
  8. MDL 28170
    A4412 MDL 28170
    Target: Cathepsins|Calpains
    Summary: Calpain和cathepsin B抑制剂
      ≥16.75 mg/mL
      insoluble in H2O
  9. Glimepiride
    A4033 Glimepiride
    中文名: 格列美脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 磺酰脲类化合物
      ≥21.45 mg/mL
      insoluble in H2O
  10. Calpain Inhibitor I, ALLN
    A2602 Calpain Inhibitor I, ALLN
     2 Citation
    Target: Cathepsins|Calpains
    Summary: Calpain I/II/ B/L抑制剂
      ≥19.1 mg/mL
      insoluble in H2O

12件产品中的 1-10

页面
每页